Upside & The Biotech Downturn
Is the current downturn a good buying opportunity for biotech stocks? And, if so, which biotech stocks are the most promising picks for aggressive investors?
2 Biotech/Pharma Penny Stocks With “Strong Buy” Ratings – And Massive Upside Potential
Two penny stocks that boast “Strong Buy” consensus ratings from the analyst community and massive upside potential.
After Rocketing Higher, Can These 3 Biotechs Continue To Soar?
A clinical-stage biotech company focused on developing tumor-specific immunotherapies to fight multiple cancer types and which is also developing a COVID-19 vaccine that could aid in the battle against variant strains of the virus.
7 Biotech Stocks With Catalysts Beyond COVID
Covid-19 vaccines aren’t the only ones you should be paying attention to” – and they highlight seven “second-tier” biotechs with catalysts beyond COVID-19 vaccines that may be worth considering.
What’s Buyable In Biotech After Recent Pullback?
The recent pullback in biotech “offers a chance to get into exciting areas of biotech research like gene editing and oncology at better prices.”
2 Clinical-Stage Biotechs With Upside Potential Over 100%
Two clinical-stage biotech stocks with the potential to deliver gains of 100% or more.
Why This Could Be The Best Coronavirus Stock “Even In A World Without COVID-19”
What makes the genetic testing and sequencing company featured in today’s article potentially the best coronavirus stock investors can buy right now?
With Biotech “Stronger Than Ever” In 2021, Here Are The 15 Fastest-Growing Biotech Companies In The U.S.
As a result of rising demand, artificial intelligence, increasing partnerships and scientific breakthroughs, Deloitte declared in a January report that the life sciences industry, including biotechnology, will be “stronger than ever” in 2021.
A Lucrative Opportunity At The $50 Billion Intersection Of Biotech And Cannabis
The company featured in today’s article finds itself at the intersection of biotech and cannabis – an intersection that could be worth $50 billion by 2029.
Is Biotech Acting More Than A Bit Like Bitcoin?
New Biotech World Order – surging share prices and booming initial public offerings of biotech stocks.